Rahahlah, N.; Al-Alami, Z.; Alorjani, M.S.; Al-Smadi, A.; Obeidat, S.; Otoom, R.; Al-Zoubi, R.M.; Al Bashir, S.; Al Zoubi, M.S.
AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. Int. J. Mol. Sci. 2026, 27, 4228.
https://doi.org/10.3390/ijms27104228
AMA Style
Rahahlah N, Al-Alami Z, Alorjani MS, Al-Smadi A, Obeidat S, Otoom R, Al-Zoubi RM, Al Bashir S, Al Zoubi MS.
AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. International Journal of Molecular Sciences. 2026; 27(10):4228.
https://doi.org/10.3390/ijms27104228
Chicago/Turabian Style
Rahahlah, Nuseibah, Zina Al-Alami, Mohammed S. Alorjani, Asmaa Al-Smadi, Sewar Obeidat, Raed Otoom, Raed M. Al-Zoubi, Samir Al Bashir, and Mazhar Salim Al Zoubi.
2026. "AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort" International Journal of Molecular Sciences 27, no. 10: 4228.
https://doi.org/10.3390/ijms27104228
APA Style
Rahahlah, N., Al-Alami, Z., Alorjani, M. S., Al-Smadi, A., Obeidat, S., Otoom, R., Al-Zoubi, R. M., Al Bashir, S., & Al Zoubi, M. S.
(2026). AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. International Journal of Molecular Sciences, 27(10), 4228.
https://doi.org/10.3390/ijms27104228
